Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Gritstone bio, Inc. (GRTS)

Core Viewpoint - A securities class action lawsuit has been filed against Gritstone bio, Inc. for allegedly making false and misleading statements regarding its Phase 2b CORAL Study and its financial position, impacting investors who purchased securities between March 9, 2023, and February 29, 2024 [1][3]. Group 1 - The lawsuit was filed in the United States District Court for the Northern District of California on behalf of all persons and entities who purchased Gritstone securities during the specified class period [1]. - Investors are encouraged to contact the law firm Gainey McKenna & Egleston before the lead plaintiff motion deadline of August 6, 2024 [2]. - The complaint alleges that Gritstone misrepresented its ability to launch the Phase 2b CORAL Study on time, which would affect its funding and overall financial health [3]. Group 2 - The lawsuit claims that Gritstone overstated its capability to develop and commercialize its products, leading to materially false and misleading public statements [3]. - Investors reportedly suffered damages when the true details about Gritstone's situation became known [3].